Reata Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Reata Pharmaceuticals

06/05/2021 15:42

* Reata Pharmaceuticals Inc  RETA.OQ  reported a quarterly
adjusted loss of $1.86​​ per share for the quarter ended
in March. The mean expectation of eight analysts for the quarter
was for a loss of $2.10 per share.
* Revenue fell 30.2% to $944.00 thousand from a year ago​; 
analysts expected $1.19 million.
* Reata Pharmaceuticals Inc's reported EPS for the quarter was a
loss of $1.86​.
* The mean earnings estimate of analysts had risen by about 3.2%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Reata Pharmaceuticals Inc shares had fallen by 8.7% this
quarter and lost 26.4% so far this year.
* The company reported a quarterly loss of $67.46 million.
* Wall Street's median 12-month price target for Reata
Pharmaceuticals Inc is $234.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 8 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated May 6 at 02:41 p.m. GMT. ​All
figures in US Dollars.​